Definitive Contract HT942525CE022
- Not listed
- The Defense Health Agency awarded a $1,999,090.13 Small Business Innovation Research (SBIR) Phase II contract to Ifyber LLC, a for-profit limited liability company, for the development of a rapid field testing capability for total coliform and E. coli in water samples. The contract, which is a firm fixed-price definitive contract, is intended to support medical research and development and has a completion date of January 23, 2023. The contract was awarded on August 27, 2018 under the DHA 2017.1...
- This is a Small Business Innovation Research (SBIR) Phase I research and development contract awarded by the Defense Health Agency (DHA) to SPZ Technologie LLC, a for-profit limited liability company. The $162,326.22 firm fixed-price contract is for the development of a "Novel Cell-Based Biosensor for Rapid Field Water Toxicity Detection" under Topic DHA191-006. The contract was set aside for small businesses and has a completion date of February 7, 2020. As an SBIR Phase I award, this...
- This is a firm fixed price purchase order (contract) awarded by the Defense Health Agency to Biobot Analytics Inc., a self-certified small disadvantaged business, to provide SARS-COV-2 analytical services. The contract is valued at $129,600.00 and has a completion date of March 13, 2025. The original solicitation was set aside for total small business and required the contractor to provide ribonucleic acid (RNA) virus detection using quantitative polymerase chain reaction (qPCR) and reverse...
- The Defense Health Agency (DHA) awarded a $249,938.77 Small Business Innovation Research (SBIR) Phase I contract to Genecapture, Inc., a for-profit startup company located at the Hudson Alpha Institute for Biotechnology. The contract is for the project titled "Expanding Genecapture's Rapid Portable Invasive Fungal Infection (IFI) Diagnostics for Wound Infections." Genecapture develops rapid infectious disease detection solutions using their patented CAPTURE technology, which identifies...
- This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES" and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...
- This is a $3,120.00 firm fixed price purchase order contract awarded to Biobot Analytics Inc., a self-certified small disadvantaged business, by the Medical Command (MEDCOM) component of the U.S. Department of Defense. The contract is for COVID-19 wastewater sample analysis services, with a performance period ending on June 1, 2022. Biobot Analytics has prior experience providing wastewater-based monitoring services to government agencies, including contracts with the National Institutes of...
- The Defense Health Agency awarded a $173,390 firm fixed-price purchase order to Phigenics LLC on October 1, 2021, for courier sampling, processing, and water testing services to be performed in San Diego, California. The contract, which carries an ultimate completion date of September 30, 2026, was issued without a set-aside designation following a competitive solicitation posted on September 20, 2021. Phigenics LLC, a for-profit limited liability company headquartered in Warrenville,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,750 firm fixed-price purchase order to Expotech U.S.A., Inc. for water sampling testing services. The contract, issued on May 9, 2025, with an ultimate completion date of May 29, 2025, carries no small business set-aside designation. Performance will occur at the contractor's Houston, Texas location. This procurement supports the Defense Logistics Agency's broader mission to provide essential supplies and services...
- This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Nanohmics Inc., a for-profit small business organization, for the Phase I research and development of a "Novel Fluorescence Lysosomal Yeast (FLY) Portable Biosensor for General Water Toxicity Testing". The contract was set aside for small businesses, has a potential value of $162,499.68, and was awarded on July 8, 2019 with a completion date of February 7, 2020. The research was conducted under the...
- Idexx Laboratories Inc., Water Division, was awarded a $380 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to provide water sampling and testing services. The contract has a period of performance through February 10, 2021 to support the agency's medical supply chain and readiness programs. As no set-aside designation was specified, this was an unrestricted award available to all qualified...
The Defense Health Agency has awarded a $1.3 million firm fixed-price contract to Godx Inc., a minority-owned small business, for the rapid identification of pathogens from water and wastewater. The contract, awarded September 15, 2025, represents a Small Business Innovation Research (SBIR) Program Phase II action with an ultimate completion date of January 14, 2028. Work will be performed in Madison, Wisconsin. This award supports the Defense Health Agency's mission to protect the health and readiness of the military community by enabling rapid pathogen detection capabilities that can be deployed in operational environments. Godx Inc. brings relevant expertise in developing point-of-care diagnostic tests for infectious disease detection. The company has an established track record with federal health agencies, including prior contracts and grants from the National Institute of Allergy and Infectious Diseases for rapid diagnostics targeting enteric pathogens, antibiotic resistance, sexually transmitted infections, and diarrheal disease agents. The SBIR Phase II award builds on the company's technical foundation in nucleic acid amplification, sample preparation, and lateral flow detection technologies, applying these capabilities to water and wastewater pathogen identification—a capability relevant to force protection and public health readiness in military and deployed settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $589.6k | 9/8/25 |